The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide

被引:4
|
作者
Mathioudakis, Alexander G. [1 ,2 ,3 ]
Mastoris, Ioannis [3 ,4 ]
Chatzimavridou-Grigoriadou, Victoria [2 ,3 ]
Mathioudakis, Georgios A. [2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Chest Ctr, Liverpool L9 7AL, Merseyside, England
[2] Athens Breath Ctr, Athens, Greece
[3] Hellen Soc Adv Biomed Res, Resp Assembly, Athens, Greece
[4] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
关键词
Tiotropium; Arrhythmia; Mortality; COPD; Therapeutics; Human; COPD; HANDIHALER; MORTALITY; RESPIMAT; INHALER;
D O I
10.1016/j.ijcard.2015.06.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:105 / 106
页数:2
相关论文
共 50 条
  • [21] What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Seamus Kent
    Iryna Schlackow
    Jingky Lozano-Kühne
    Christina Reith
    Jonathan Emberson
    Richard Haynes
    Alastair Gray
    Alan Cass
    Colin Baigent
    Martin J Landray
    William Herrington
    Borislava Mihaylova
    BMC Nephrology, 16
  • [22] What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent, Seamus
    Schlackow, Iryna
    Lozano-Kuehne, Jingky
    Reith, Christina
    Emberson, Jonathan
    Haynes, Richard
    Gray, Alastair
    Cass, Alan
    Baigent, Colin
    Landray, Martin J.
    Herrington, William
    Mihaylova, Borislava
    BMC NEPHROLOGY, 2015, 16
  • [23] The effect of tiotropium/olodaterol fixed-dose combination on cardiac function in patients with newly diagnosed moderate-to-severe chronic obstructive pulmonary disease
    Dimiene, Ieva
    Padervinskiene, Lina
    Jermalaviciene, Inesa
    Hoppenot, Deimante
    Miliauskas, Skaidrius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] Effects of Tiotropium Bromide on Patients with Chronic Obstructive Pulmonary Disease
    Li, Zhiying
    Zhou, Lin
    Bi, Hui
    Zhang, Qiudi
    Xu, Xiong
    Liu, Yuwen
    Qiu, Hui
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (02) : 215 - 220
  • [25] Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase IIIb Study
    Beier, Jutta
    Kirsten, Anne-Marie
    Mroz, Robert
    Segarra, Rosa
    Chuecos, Ferran
    Caracta, Cynthia
    Garcia Gil, Esther
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 511 - 522
  • [26] Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases
    Lin, Jieshan
    Tang, Bin
    Feng, Zhanwu
    Hao, Wenke
    Hu, Wenxue
    BMC NEPHROLOGY, 2021, 22 (01)
  • [27] Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease
    González, C
    Servera, E
    Ferris, G
    Blasco, ML
    Marín, J
    ARCHIVOS DE BRONCONEUMOLOGIA, 2004, 40 (11): : 502 - 507
  • [28] Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases
    Jieshan Lin
    Bin Tang
    Zhanwu Feng
    Wenke Hao
    Wenxue Hu
    BMC Nephrology, 22
  • [29] A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus
    Yosipovitch, Gil
    Awad, Ahmed
    Spencer, Robert H.
    Munera, Catherine
    Menzaghi, Frederique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 261 - 268
  • [30] Risk factors for moderate-to-severe chronic graft-versus-host disease in children
    Svennilson, J
    Remberger, M
    Gustafsson, B
    Gustafsson Jernberg, A
    Winiarski, J
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S208 - S208